VASOPRESSIN Pharmacologic Class Indexing
- Class set ID
- 87ee6044-dcd1-41b0-9dac-95b10238f436
- Version
- 1
- Effective date
- 20210721
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| 52324969-4536-2b7c-e063-6394a90a9b4d | HF Acquisition Co LLC, DBA HealthFirst | 20260519 | 1 |
| 5232a8bc-d7ae-48a5-e063-6294a90a76ca | HF Acquisition Co LLC, DBA HealthFirst | 20260519 | 1 |
| These highlights do not include all the information needed to use VASOPRESSIN INJECTION, safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use. VASOPRESSIN in dextrose injection for intravenous use Initial U.S. Approval: 2014 | Gland Pharma Limited | 20250826 | 9 |
| These highlights do not include all the information needed to use VASOPRESSIN IN SODIUM CHLORIDE INJECTION safely and effectively. See full prescribing information for VASOPRESSIN IN SODIUM CHLORIDE INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Long Grove Pharmaceuticals, LLC | 20250617 | 10 |
| These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Civica, Inc. | American Regent, Inc. | 20250301 | 2 |
| These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Fresenius Kabi USA, LLC | 20250227 | 2 |
| These highlights do not include all the information needed to use VASOPRESSIN IN SODIUM CHLORIDE INJECTION safely and effectively. See full prescribing information for VASOPRESSIN IN SODIUM CHLORIDE INJECTION . VASOPRESSIN IN SODIUM CHLORIDE INJECTION, for intravenous use Initial U.S. Approval: 2014 | Baxter Healthcare Corporation | 20250221 | 5 |
| These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Fresenius Kabi USA, LLC | 20250215 | 9 |
| These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Sagent Pharmaceuticals | 20241109 | 1 |
| These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | American Regent, Inc. | 20241031 | 14 |
| These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION . VASOPRESSIN injection, for intravenous use Initial U.S. Approval: 2014 | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals Private Limited | Steril-Gene Life Sciences Private Limited | 20240707 | 13 |
| These highlights do not include all the information needed to use VASOPRESSIN INJECTION safely and effectively. See full prescribing information for VASOPRESSIN INJECTION. VASOPRESSIN injection for intravenous use Initial U.S. Approval: 2014 | Amphastar Pharmaceuticals, Inc. | 20220822 | 2 |